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Background: Most infections with human papillomavirus (HPV) are resolved without clinical intervention, but a
minority evolves into chronic lesions of distinct grades, including cervical-uterine cancer. It is known that in most
cases the immune system mediates elimination of HPV infection. However, the mechanism of immune evasion
leading to HPV persistence and development of early cervical lesions is not fully understood. The aim of the present
work was to evaluate the potential of peripheral blood leukocytes (PBL) from low-grade squamous intraepithelial
lesions (LSIL) patients to be activated ex-vivo by vaccine antigens, the participation of cytotoxic lymphocytes and
regulatory T cells, and to determine the secretion of Th1 and Th2 cytokines mediated by stimulation of T cell
receptors.
Results: We found that PBL from LSIL patients showed a significantly lower proliferation rate to vaccine antigens as
compared to that of healthy donors, even though there was not a difference in the presence of antibodies to those
antigens in sera from both groups. We did not find differences in either the frequency of CD4 + CD25 + FoxP3+ in
PBL, or the levels of IL-4, IL-5 and IL-10 in plasma or conditioned media from PBL incubated with TcR agonists
in vitro, between the two groups. However, we detected a lower production of IL-2 and a higher proportion of
CD8 + IFNγ+ cells in PBL from LSIL patients as compared with PBL from normal donors. We also observed that PBL
from patients infected by HPV-16 and −18 were not able to proliferate in the presence of soluble HPV antigens
added to the culture; however, a high level of proliferation was attained when these antigens were presented by
activated dendritic cells.* Correspondence: mogl@servidor.unam.mx
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http://www.infectagentscancer.com/content/7/1/12Conclusions: Our results suggest that the immunodeficiency reported in LSIL patients could be due to the inability
of specific cytotoxic T lymphocytes that for some unknown reason are present but unable to mount a response
when challenged with their antigens, probably related to an in situ IL-2 production deficiency.
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Evasion of the immune response by malignant cells is asso-
ciated with the development of neoplastic diseases. Several
mechanisms have been described that negatively regulate the
immune system against foreign antigens. Among these
mechanisms a bias in the secretion of cytokines produced by
Tcells towards the Th2 profile (IL-10, IL-4) as well as the in-
hibition of cytotoxic T cells (CTLs) has been proposed [1]. It
has also been suggested that an increased activity of regula-
tory T cells may prevent an effective immune response
against transformed cells and associated pathogens [2,3].
Cervical cancer (CeCa) is strongly associated to Human
Papillomavirus (HPV) infection, and the progression of the
disease depends on continuous viral replication and the
eventual integration of the viral genome into the host gen-
ome [4]. The presence of specific T lymphocytes to HPV
antigens in healthy subjects and in patients with different
degrees of illness has been described [5]. The biological sig-
nificance of these responses in healthy individuals has been
interpreted as the mark left by successful virus elimination
[6]; however, the presence of this response in patients with
CeCa might indicate a poor ability of the lymphocytes to
eliminate the virus. Specific T cell responses to various HPV
proteins have been found, indicating that viral antigen rec-
ognition is a constant during the different phases of viral in-
fection [5]. The presence of CD8+ IFNγ+ lymphocytes is a
normal occurrence since the early stages of viral infection
[7]. However, in a number of cases their activity is unable to
eradicate infected cells, which may contribute to the devel-
opment of malignancy.
It is known that activation of CD8+ effector T cells
requires the collaboration of CD4+ T cells, in particular for
the generation of memory clones. In turn, the initial activa-
tion of naive CD4+ and CD8+ T cells depends on specific
antigen presentation by activated dendritic cells. Antigen
presentation and cellular effector activity during an antiviral
response are regulated by cytokines such as IL-2, IL-12 and
IFNγ. However, the instructive mechanisms that define the
outcome of the antigen-presenting cells to T lymphocytes
have not been fully elucidated [8]. In the case of HPV, the
nature of antigen presentation and the resulting effector re-
sponse is hampered by the fact that HPV does not have an
active lytic phase, thus limiting the inflammatory process,
which seems to be an important requirement for activation
of antigen-presenting cells [9].
The purpose of this study was to evaluate the capability
of T lymphocytes from Low-grade Squamous IntraepithelialLesions (LSIL) patients to be activated by vaccine antigens.
The participation of dendritic cells, CD8+ IFNγ cells and
Treg cells during T cell activation was also determined. In
addition, the production of Th1- and Th2-type interleukins
by T cells stimulated by a CD3/CD28 agonist was quantified
in an attempt to identify host factors associated with the de-
ficient anti-HPV response known to be present in LSIL
patients.
Materials and methods
Subjects and biological samples
Patients attending the Clinic of Dysplasias of the Cruz-
Talonia Foundation were studied. Informed consent was
obtained from all women included in this work. Human
material was handled according to institutional experi-
mentation and safety guidelines. The study population
was selected from women referred for colposcopy due to
abnormal cytology (n = 20), and women without a history
of cervical abnormalities who attended the clinic for rou-
tine gynecological examination (n = 20). All women
underwent cytological and histopathological analysis of
colposcopy-directed samples. Cytology diagnosis was
classified according to the Bethesda system [10]. Colpos-
copy-directed biopsies were obtained from acetowhite or
normal tissue around the transformation zone. Tissue
samples were placed in tubes containing sterile, contam-
inant-free phosphate-buffered saline and processed the
same day for DNA isolation. Blood samples were
obtained from either 20 LSIL patients, or 20 normal
donors with normal cytology as control and a group of 5
young healthy women who were previously vaccinated
with three doses of GardasilW (Merck S&D, USA).
HPV DNA detection by PCR
All reagents used for the isolation and amplification of
DNA were purchased from Invitrogen, USA. Cervical bi-
opsies were treated with proteinase K. DNA was
extracted with phenol/chloroform and precipitated with
ethanol. HPV DNA was amplified using the general pri-
mers MY09 (5’-CGTCCMARRGGAWACTGATC-3′)
and MY11 (5′-GCMCAGGGWCATAAYAATGG-3′),
which amplify a conserved 450-bp fragment from the L1
gene [11]. Genomic DNA (100 ng) was denatured by
heating to 95 °C for 30 s. Annealing of primers was per-
formed at 45 °C for 30 s and extension at 72 °C for 60 s.
The cycle was repeated 30 times. Specific amplification of
HPV-6, -11, -16, -18, -31, -33, -39, -45, -52, and −58 was
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previously described in [12]. Genomic DNA (100 ng) was
denatured by heating to 95 °C for 60 s. Annealing of pri-
mers was performed at 45 °C for 2 min and extension at
72 °C for 90 s. The cycle was repeated 40 times. To en-
sure DNA integrity, the β-actin gene was amplified for all
samples.
Lymphocytes proliferation assay
Serum from blood samples was separated from the cellu-
lar fraction by centrifugation. Serum samples were heat-
inactivated by incubation at 57 °C for 30 min and then
crio-preserved at −70 °C until use. The cellular fraction
was mixed 1:1 v/v with PBS, loaded onto a 1.077 Histo-
paque gradient (Sigma-Aldrich, USA) and centrifuged to
isolate the layer containing the peripheral blood leuko-
cytes (PBL). 5×105 PBL were seeded in 96-microwell
plates (Corning, USA) in 200 μL of IMDM (Invitrogen,
USA) supplemented with 10% of autologous serum
(IMDM10S), either with medium alone, in the presence
of 1 μL of Infanrix HexaW (GSK Biomedicals, Belgium)
corresponding to 6×10-2 IU of diphtheria, 8×10-2 IU of
tetanus, 50 ng of pertussis, 20 ng of hepatitis B, and
0.16 IU of polio antigens, or in the presence of 1 μL of
CervarixW (GlaxoSmithKleen, Belgium) corresponding to
40 ng of each HPV-16/-18 L1 proteins, for 5 days. Thus,
the assay consisted of three sets of samples: a) LSIL, b)
normal, and c) young women vaccinated with GardasilW.
Each set of samples was challenged with CervarixW or
InfanrixW. We used as a control a culture in the absence
of antigen. Then, 0.5 μCi of tritiated thymidine (Dupont
NEN, USA) was added per well and incubated for an-
other 16 hours. Finally the PBL cells were harvested and
the incorporation of tritiated thymidine determined. The
proliferation index corresponded to the ratio of: the cpm
of cells incubated with antigen/cpm of control cells for
each sample.
Enzyme-linked immuno sorbent assay (ELISA)
Serum antibodies from patients with LSIL and from
healthy donors were tested in ELISA. For this pourpose,
immuno-plates (Costar-Corning,USA) were coated with
50 μL/well of Infanrix HexaW or with 50 μL/well of Cer-
varixW diluted 1:20 in PBS and incubated at 4 °C over-
night. Plates were washed and non-specific binding sites
were blocked with 2% BSA (Research Organics, USA) for
2 hr at 37 °C. Then 50 μL of blood serum diluted 1:500
were added to the plate and incubated for 2 hr at 37 °C.
50 μL of alkaline phosphatase-conjugated goat-anti
human IgG (Invitrogen, USA) diluted 1:5000 were added
and incubated for 1 hr at 37 °C. Alkaline phosphatase
substrate (Sigma-Aldrich, USA) diluted in a 10% (w/v)
diethanolamine solution (Sigma-Aldrich, USA) was fi-
nally added to the plates. The absorbance was read at405 nm in an ELISA plate reader (Molecular Devices,
USA). The final values were obtained after subtracting
the non-specific absorbance reactivity obtained in wells
with saline to the reactivity obtained in wells with
antigen.
Determination of CD4+CD25+ FoxP3+ cells by flow
cytometry
5×105 PBL were incubated with 1 μL of antiCD4/PerCP
(R&D Systems, USA) and 1 μL of antiCD25/PE (R&D
Systems, USA) at 4 °C for 30 min, washed twice and sub-
sequently permeabilized and labeled with antiFoxP3/
APC (eBioscience, USA) and isotypes involved. After
three final washes, the cells were fixed with 2% parafor-
maldehide (Sigma-Aldrich, USA) and the percentage of
CD4+CD25+ FoxP3+ cells was determined by flow
cytometry (FacsAriaII, BD, USA).
Isolation and maturation of monocytic-derived dendritic
cells
PBL were fractionated by adherence to plastic dishes
during 2 hr at 37 °C. The adherent fraction was then cul-
tured for 4 days in IMDM-10S supplemented with
30 ng/ml of rhGM-CSF (R&D Systems, USA) and 20 ng/
mL of rhIL-4 (R&D Systems, USA). The cells were then
harvested, washed and incubated for one hour with 5
μL/mL of CervarixW at 37 °C. Finally the cells were kept
in culture for two days more in IMDM-10S with rhGM-
CSF, rhIL-4 and 20 μg/mL of poly I:C (Sigma- Aldrich,
USA), to induce their maturation, either in the presence
or in the absence of 1μL of CervarixW.
Lymphocytes proliferation induced by dendritic cells
assay
PBL from two patients (one positive for HPV-16 and
other for HPV-18) were induced to proliferate in the
presence of L1 from HPV-16 and −18 processed and pre-
sented by either a): monocytic cells or b): dendritic cells.
For this purpose: a) PBL were incubated with 2 μM of
carboxyfluorescein (CFSE) (Sigma-Aldrich, USA) during
15 min at room temperature (RT). After three washes
with IMDM10S, 5x105 cells were incubated in 200 μL of
IMDM10S during 5 days either with 1 μL of CervarixW,
or in absence of antigen, as a control. b): PBL were la-
beled with CSFE during 15 min, RT, washed three times
and then either incubated with autologous monocytic-
derived dendritic cells loaded during maturation with
1μL of CervarixW, or with autologous dendritic cells used
as a control. After 5 days the cells were harvested and
stained with 1μL of CD4/PE antibodies (R&D Systems,
USA) and 1 μL of CD8/APC antibodies (R&D Systems,
USA) at 4 °C during 30 min. The decrease in the carbox-
yfluorescein label was assessed by flow cytometry, and
used as an indicator of proliferation.
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5×105 PBL were seeded in 96-microwell plates (Corning,
USA) in 200 μL of IMDM10S, in the presence of phyto-
hemagglutinin (PHA) (Invitrogen, USA) dilute 1:100 as
the final concentration, or in absence of PHA as a con-
trol, for 5 days. After this time, the cells were harvested
and stained with 1 μL of CD8/APC and 1 μL of IFNγ/
FITC (R&D Systems, USA), for 30 min at 4 °C, and finally
evaluated in a FACSAria II cytometer (BD, USA). The
percentage of CD8+ IFNγ+ cells was determined for each
sample based on the total cell number recovered in the
culture.
Quantification of cytokines
5×105 PBL were incubated in 200 μL of IMDM-10S with
2.5 μL of antiCD3/CD28 beads (Dynabeads CD3/CD28
Human T-Activator, Invitrogen, USA). After 4 days, the
conditioned medium was collected and stored at −70 °C.
The concentration of cytokines was determined by flow
cytometry according to manufacturer’s instructions
(Cytometric Bead Array: Human Th1/Th2 cytokine kit,
BD Biosciences, USA). Plasma cytokines levels were
determined with the same Th1/Th2 cytokine kit from
peripheral blood samples, after separation of the cellular
fraction, also according to manufacturer’s instructions.
Statistical analysis
All samples were tested in triplicate and the numerical
data are expressed as an average of the values obtained.
The non-parametrical Man-Whitney U test was used to
compare the mean of the pertinent groups. A P <0.05
was considered statistically significant.
Results
Lymphocytes from LSIL patients had a significantly lower
response to vaccine antigens than normal donors
After clinical and molecular diagnosis, subjects were
divided into two groups: the LSIL group (n=20; mean age:
26.65 years, range: 18–35 years), and the normal donor
group (n= 20; mean age: 37.93 years, range: 22–46 years).
HPV analysis showed that five LSIL samples were positive
for the presence of HPV DNA. Genotyping of these posi-
tive samples demonstrated the presence of individual in-
fection by HPV types 6, 11, 16, 18 and 58. These samples
were included in the set of 20 that formed the group
named LSIL in the assays. In order to assess the presence
of cells reactive to well known antigens, PBL from LSIL
patients, women vaccinated with GardasilW, and normal
controls were incubated with Infanrix HexaW, a vaccine
that is administrated in Mexico as a part of the national
vaccination campaign. As expected, cells from normal con-
trols and women vaccinated with GardasilW were able to
proliferate in the presence of the antigens contained in
InfanrixW. In contrast, PBL from LSIL patients showed aresponse to the vaccine that was significantly lower than
the detected in normal donors (Figure 1). To demonstrate
that the response was directed against an already known
antigen, PBL were also incubated with CervarixW, a vac-
cine that contains antigens from HPV16 and HPV18. In
Mexico, administration of CervarixW is basically restricted
to private practice; therefore women included in this work
have not been vaccinated with this vaccine. As shown in
figure 1, cells from women vaccinated with GardasilW pro-
liferated as a response to the viral antigens contained in
CervarixW. Interestingly, cells from both HPV-infected and
non-infected LSIL women showed a negative response,
that was similar to that detected in normal controls. These
results suggest the existence of a deficiency on the re-
sponse of T cells from patients with LSIL.
Serum antibodies to vaccine antigens are found in LSIL
patients and normal donors
Our results showed a decreased T cell response in LSIL
patients. Thus, to determine if the antibody response was
also diminished, we evaluated the presence of antibodies to
InfanrixW in sera from LSIL patients and normal controls
by ELISA using InfanrixW as target antigens. We detected
similar antibody levels in serum samples from LSIL patients
and normal donors without HPV infection (2.35±0.66 and
1.96±0.76, respectively) (Figure 2). These results suggest
that the difference in Tcell responses between LSIL patients
and normal controls is not associated with a reduced func-
tion of B lymphocytes. Additionally, we tested the presence
of antibodies specific to L1 from HPV-16 and −18 in the
sera of LSIL patients and normal donors, and obtained a
minimal response; in contrast, we found those specific anti-
bodies in sera from young women vaccinated with Garda-
silW (composed by L1 from HPV-6, -11, -16 and −18).
Similar levels of CD4+CD25+ FoxP3+ lymphocytes were
present in PBL from LSIL patients and normal donors
In order to evaluate if the diminished T cell response in
LSIL patients is associated with the presence of Treg
cells, we evaluated the levels of CD4+CD25+ FoxP3+
cells. No significant difference was found in the propor-
tion of CD4+CD25+ FoxP3+ cells in PBL from LSIL
patients (3.96 ± 1.00) and normal controls (3.51 ± 1.18)
(Figure 3). These results suggest that Treg cells do not
account for the deficient antigen recognition by PBL
cells in LSIL patients.
PHA induces the production of IFNγ by CD8+
lymphocytes from LSIL patients
Our results indicate that the lack of lymphocyte response
in LSIL patients is not due to negative regulation by Treg
cells. Therefore, we next investigated whether CD8+
IFNγ+ lymphocytes, which are known to play an active
role during anti-viral responses, can be activated in these
* 
A) B)
Figure 1 Response of PBL from LSIL patients and normal donors to already known antigens. A) PBL from LSIL patients (LSIL) (n = 20),
normal donors (Normal) (n = 20), and women vaccinated with GardasilW (Gsl) (n = 5), were incubated with antigens from Infanrix HexaW, a vaccine
containing antigens of diphtheria, tetanus, pertussis, hepatitis B and poliovirus, which is administered during childhood. B) PBL from LSIL patients
(LSIL) (n = 20), normal donors (Normal) (n = 20), and women vaccinated with GardasilW (Gsl) (n = 5) were incubated with GardasilW a recombinant
vaccine containing capsid antigens from HPV16, and HPV18. Proliferation was determined by means of thymidine incorporation after 5 days
incubation, and the proliferation index corresponded to cpm in the presence of antigen/cpm control without antigen. A statistical significant
difference was found between LSIL and normal groups (* p< 0.005).
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stimulated with PHA. The proportion of CD8+ IFNγ+
cells was determined by flow cytometry. We observed a
high proportion of CD8+ IFNγ+cells in the PBL from
LSIL patients, while almost no lymphocytes of this pheno-
type were detected in the normal donors (Figure 4). These
results suggest the presence of inducible CD8+ IFNγ+
cytotoxic lymphocytes in LSIL patients.
Lymphocytes from LSIL patients were strongly induced to
proliferate in the presence of dendritic cells
Our results indicate that subpopulations of inducible
CD8+ IFNγ+ cytotoxic lymphocytes are present in LSIL
patients. However, it is known that activation of CD8+
cells depends on specific antigen presentation by activatedA) B
Figure 2 A) Seroreactive response of normal donors (Normal) and LSI
presence of IgG antibodies specific to Infanrix HexaW antigens (diphtheria,
Infanrix Hexa antigens were diluted 1:20 to cover plate and serum samples
significant difference between LSIL and the normal group was found. (B) S
and women vaccinated with GardasilW to CervarixW antigens. Analysis of th
HPV-16 and −18 capsids) was determined by ELISA. CervarixW antigens wer
assay their seroreactivity. No statistically significant difference between LSILdendritic cells. Therefore, we next evaluated whether
lymphocytes from LSIL patients could be activated to pro-
liferate as a response to already known viral antigens pre-
sented by autologous dendritic cells. PBL from two LSIL
patients, were co-cultured with dendritic cells or dendritic
cells previously “loaded” with CervarixW. The first patient
was infected by HPV18; the second one was infected by
HPV16, as demonstrated by PCR. Proliferation of PBL was
determined. As shown in Figure 5, PBL from the patients
were able to proliferate in the presence of HPV antigens
alone. Co-culture with dendritic cells induced a modest in-
crement in PBL proliferation. However, activation by pre-
loaded dendritic cells induced a dramatic increase in PBL
proliferation in both patients. These results indicate that
PBL from LSIL patients are able to recognize and proliferate) 
L patients (LSIL) to Infanrix HexaW antigens. Analysis of the
tetanus, pertussis, hepatitis B and poliovirus) was determined by ELISA.
were diluted 1:500 to assay their seroreactivity. No statistically
eroreactive response of normal donors (Normal), LSIL patients (LSIL)
e presence of IgG antibodies specific to CervarixW (L1 protein from
e diluted 1:20 to cover plate and serum samples were diluted 1:500 to
and the normal group was found. O.D.: Optical density.
Figure 3 Characterization of the presence of cells with
regulatory phenotype in peripheral blood lymphocytes from
patients with LSIL (LSIL) and donors without HPV (Normal).
Peripheral blood mononuclear cells isolated from healthy donors
and from LSIL patients were analyzed without previous stimulation
for surface expression of CD4 and CD25 and intracellular expression
of FoxP3. CD4+CD25 + FoxP3+/CD4+ cells ratios were determined
for each sample. No statistically significant difference between LSIL
and the normal group was found.
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response completely depends on the presentation of anti-
gens by activated dendritic cells.Lymphocytes from LSIL patients produce lower levels of
IL-2 than those from normal donors
Our results have shown that PBL from LSIL patients can be
specifically activated by dendritic cells presenting an already
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Figure 4 Proliferation of CD8+ IFNγ+ cells from LSIL patients (LSIL), a
phytohemagglutinin (PHA). PBL from LSIL patients were cultured for 3 da
intracellular IFNγ expression. The proportion of CD8+ IFNγ+ stimulated by P
obtained from PBL of a LSIL patient incubated with phytohemagglutinin (P
plot obtained from PBL of a normal donor incubated with phytohemagglu
CD8+ IFNγ+percentages for each set of samples. Error bars indicate the st
found between the groups with a p< 0.05*.cellular effector activity during a viral infection are regulated
by cytokines, we evaluated the levels of serum IL-2, IL- 4,
IL-6, IL-10, TNFα and IFNγ from LSIL patients and normal
controls. No differences in concentration of any of the cir-
culating cytokines tested were found between LSIL patients
and normal controls (data not shown). Thus, we decided to
explore the production of these cytokines by LSIL and nor-
mal control PBL after the induction of proliferation by an
agonist of CD3/CD28. We observed that the PBL from
LSIL patients and normal controls produced and secreted
similar levels of IL-4, IL-5, IL-10, IFNγ, and TNFα. How-
ever, production of IL-2 was significantly reduced in LSIL
patients (Figure 6). These results seem to indicate that pro-
duction and secretion of the main regulator of T cell activa-
tion, IL-2, is highly compromised in LSIL patients.Discussion
Progression of precursor lesions (LSIL and HSIL) to-
wards cervical cancer has been associated with persistent
infection by oncogenic HPV types, along with local and
systemic immune abnormalities, which may lead to
impaired function of the T cell response. Most LSIL are
expected to undergo a spontaneous regression [13],
which is normally associated with the development of an
efficient cellular response to HPV antigens [14]. In the
present work we have shown that LSIL patients exhibit a
deficient T cell response, not only to HPV antigens, but
also against various types of antigens, and that the lack
of response is unrelated with a current HPV infection.
Lymphocytes from LSIL patients showed significantly
less proliferation as a response to already known vaccine
antigens and to HPV-derived antigens, than those from*
)
nd normal donors (Normal) after stimulation with
ys in the presence of PHA, and then analysed for surface CD8 and
HA were evaluated by flow cytometry. A) shows a representative plot
HA) and in absence of PHA, as a control (−). B) shows a representative
tinin (PHA) and in absence of PHA (−). Bars in C) depict the mean of
andard error of the mean. A statistically significative difference was
0.28
0.16 0.74 3.58 16.22
5.922.500.43




a) b) c) d)
Figure 5 Proliferation of PBL from LSIL patients in response to HPV antigens presented by monocytic (a,b) and by dendritic cells (c,d).
PBL from two LSIL patients, infected by HPV-16 (P1), and HPV-18 (P2) were incubated with CervarixW, that contains capsid antigens of HPV-16, and
HPV-18, to evaluate the induced proliferation. Carboxifluorescein (CFSE) labeled PBL from patients P1 and P2 were incubated in the presence of
soluble CervarixW (PBL +Cervarix) (b), and PBL alone were used as a control (PBL) (a). CFSE labeled PBL from patients P1 and P2 were cultured
with autologous dendritic cells (PBL +DCs), previously “loaded” with CervarixW (d), or with autologous unloaded dendritic cells as a control
(PBL +DCs/Cvx) (c). The percentage of decrease in carboxiflourescein label, as an indicator of cell proliferation is shown under the bar (M1) of
each histogram.
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antibodies to these antigens were similar for both groups;
nevertheless we consider worthwhile to increase the
number of samples in the near future to generalize our
results.
Specific T cell response to cancer cells and viruses is
tightly regulated by regulatory CD4+ cells (Tregs) expres-
sing fork-head box (Fox)-P3 (CD4+CD25+FoxP3+).
Increased frequencies of circulating Tregs have been
reported in various solid tumors [15], including cervical
cancer [2,3]. Here we found that CD4+CD25+FoxP3+
regulatory cell numbers are not increased in LSIL patients.
This observation is in agreement with a previous report
showing a similar frequency of circulating CD4+ Tregs in
women with CIN0 and patients with CIN1/2 [3] and with
other report, where the higher levels of mucosal FoxP3 ex-
pression were shown in the CIN2/3 group [16]. Accord-
ingly, we did not find a correlation between the lack of
proliferation and IL-2 secretion with an increased presence
of CD4+CD25+FoxP3+ cells in our samples.
IFNγ-producing T cells play a crucial role in the elim-
ination of tumor cells [17]. It has been demonstrated
that although HPV-specific activated CD4+ and CD8+cells are detected in tumor-infiltrating lymphocytes (TIL)
and tumor-draining lymph node cells (TDLNC) of most
cervical cancer patients, only a few IFNγ-producing cells
are found in these patients, suggesting that the T cells
are functionally inactive [18]. In our work, we found that
stimulation of PBL from LSIL patients with PHA
resulted in a significantly greater proportion of CD8+
IFNγ+ cells compared with those obtained in healthy
donors, which suggest the existence of subpopulations of
responder cells with a limited state of activation in the
earliest stages of pre-malignant cervical lesions. In order
to determine whether these clones correspond to HPV-spe-
cific T cells a more thorough characterization of these
populations to identify their antigenic specificity and their
activation status is needed. Coincidently, Lee and colleagues
[19] found that CD8+ lymphocytes from LSIL or ASCUS
patients stimulated with Staphylococcus enterotoxin B had a
deficiency in the production of IL-2, but not of IFNγ, sug-
gesting that the effector ability of CD8+ cell is not affected,
although this population cannot be expanded.
We found that lymphocytes from HPV16- and HPV18-
associated LSIL were not able to proliferate in the pres-








Figure 6 Cytokines production after stimulation of antigenic receptor of PBL from patients with LSIL (LSIL) and normal donors without
HPV (Normal). PBL from LSIL patients and normal donors were stimulated in culture with CD3/CD28 activating beads. After 5 days in culture, the
concentration of: A) Th2 (IL-4, IL-5, IL-10) and B) Th1 (IL-2, TNFα, IFNγ) cytokines in supernatants were assayed by mean of a Cytometric Bead
Array. A statistically significant difference was found for IL-2 production (* p< 0.05).
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derived antigens. However, a strong T cell response was
observed when the antigens were presented by dendritic
cells. A similar observation was made in cervical cancer,
where stimulation of TIL and TDLNC with their cognate
antigen in the presence of commonly used Toll-like re-
ceptor ligands significantly enhanced the effector T-cell
function. Therefore, it is possible the presence of specific
T cells but with limited activation status due to lack of ap-
propriate stimulation since the early stages of infection
with HPV to malignant stages. The mechanisms leading
to this state of partial activation by T lymphocytes remain
to be resolved, but may be associated with the limited
antigen presentation and absence of inflammation that
occurs in the early stages of infection with HPV [9]. In
this sense, several lines of evidence show that failure in
the presentation of antigens by dendritic cells, may con-
tribute to the development of tumors [20-22].
It has been considered that an effective immune re-
sponse to HPV is based on a Th1-type reaction, which
involves cytokines such as IL-2, IL-12, TNFα and IFNγ.
It has been observed that the elimination of the virus is
preceded by the expression of Th1 cytokines in the ab-
sence of Th2-type cytokines [23], and given the antagon-
istic nature of Th1 and Th2 functions, it is assumed that
infected cells are protected from immune response when
a Th2 pattern is present, with a significant role for IL-10[24]. However, in more advanced stages, including cer-
vical cancer, it is possible to detect a large production of
cytokines of both profiles, questioning the role of Th2
profile in cervical cancer development [25]. We found
that IL-2 secretion induced by stimulation of T cell anti-
gen receptor was significantly lower in PBLs from LSIL
patients in comparison with those of healthy donors.
These results are consistent with the notion that Th1
profile is necessary for the resolution of infection, as IL-
2 production shows a deficiency that is reflected beyond
the local level, to the periphery. However, we did not
find a difference in the production of IFNγ, IL-10, and
TNFα between PBL from LSIL and normal donors. It
has been previously reported a decreased production of
IL-2 by PBL from HPV infected subjects, stimulated
in vitro with both HPV specific and unrelated antigens,
as well with polyclonal stimuli [19,26,27]. In addition, it
has been demonstrated that CD8+ T cells from LSIL
patients have a deficiency in the production of IL-2 when
they are stimulated with Staphylococcus enterotoxin B
[19]. In all these cases, a common feature was a direct
relationship between the degree of the IL-2 deficiency
and the lesion progress. One proposed explanation for
this deficiency has been a depletion of the immune sys-
tem as a result of inflammation due to HPV and other
pathogens that associate with LSIL and HSIL [19]. Other
possible causes of inhibition of proliferation and IL-2
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phocytes could be associated with metabolic process, for
example thiol-sensitive pathways, involving IL-2 [28].
However, the precise events that are lead to this defi-
ciency have not been fully determined.
The above results suggest a key role for IL-2 in the
resolution of the infection and elimination of tumors.
IL-2 concentration decreases with advancing stages of
the disease, when the production of other cytokines
show a new increase in the most advanced stages,
probably as a result of enhanced inflammation [29]. In
this respect we have previously shown that the presence of
IL- 2 receptors on cancer cells could compete for the IL-2
present in situ depleting the concentration of this growth
factor that is absolutely needed to activate cytotoxic cells
[30]. It is known that an adequate memory CD8+ T cells
setting is highly dependent on helper CD4+ T cell function,
and IL-2 has been proposed as a signal required during
priming for a secondary expansion of CD8+ T cells [31],
particularly in the case of chronic infections [32]. Therefore,
the restricted activation of CD8+ T cells detected in the
blood of LSIL patients could be explained by the defi-
ciency of IL-2 observed in these leukocytes. In
addition, CD4+ helper activity needs dendritic cells for
efficient priming of T CD8+ cells [33] which in turn
are known to be producers of IL-2 [34].
In this work we present evidence that LSIL patients
show a deficiency in the T cell response, which is not
associated with an increase in T regulatory cells or an in-
crease in Th2 inhibitory cytokines. We also showed that
PBL from LSIL patients can be activated in vitro to
recognize HPV, and significant amounts of CD8+ IFNγ+
cells can be obtained from LSIL patients after mitogenic
stimulation. However, LSIL patients are unable to mount
a specific response when challenged with those antigens
unless they are presented by autologous dendritic cells.
The fact that PBL from those patients were poor produ-
cers of IL-2 suggests that a deficiency in situ of IL-2
could be a mechanism by which infected cells escape im-
mune surveillance and thus create the conditions for the
subsequent expansion of malignant clones.
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